OrbiMed’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Hold	0	–	–	–	129
2023 Q2	–	Sell	-68,937	Closed	-$727K	–	122
2023 Q1	$727K	Buy	+68,937	New	+$727K	0.01%	112